Philips Partners with Dutch Health Insurer ONVZ for Enhanced Oral Care Prevention

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is collaborating with Dutch health insurer ONVZ to provide an industry first, strategic cooperation focused on oral care prevention. The unique partnership’s first offering is a supplementary health insurance in combination with the advanced Philips Sonicare DiamondClean Smart toothbrush.

A smart technology partnership

This collaboration combines an oral care insurance in the Netherlands, Tandfit Preventief from ONVZ, with Philips' latest connected electric toothbrush - the Philips Sonicare DiamondClean Smart - to protect against cavities, gum inflammation and other oral diseases. The insurance fully covers dental hygienist visits and dentist check-ups and includes an accident insurance and a new brush head every quarter.

With this partnership, ONVZ and Philips want to emphasize that investing in prevention, can contribute to better oral hygiene and a reduction of oral care costs.

Sinead Kwant, Business Leader of Health & Wellness at Philips, explained, "Philips and ONVZ are the first two parties to invest in oral care prevention in such a way. We share a passion and ambition in helping people live healthier lives. By offering this toothbrush in combination with the supplementary insurance, we make innovative oral health available and affordable for more people."

Personalized brushing advice

The DiamondClean Smart helps users track their daily brushing technique to tackle the ongoing challenge of not knowing how well they are doing in-between check-ups with their dentist. Thanks to its advanced smart technology, the Philips Sonicare DiamondClean Smart can be linked to an app that gives its users personalized feedback about their brushing behavior. Every brush head has a micro-chip, so all personal settings are recognized. Users can also take a progress report with them to the dental hygienist or dentist to obtain further tips and information based on their brushing behaviors. Finally, when connecting the DiamondClean Smart to the Philips Sonicare app via Bluetooth®, a 3D mouth map is visible so users can see exactly where they have brushed and where they haven’t.

The DiamondClean Smart, Philips' most innovative and intelligent toothbrush enhances Philips’ complete oral care platform, offering data driven insights to transform oral healthcare.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...